NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Paratus Sciences

Paratus Sciences

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://paratussciences.com/

Last Round

Series A

Feb 27, 2023

Total Funding Raised

$100M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Paratus Sciences is a biotechnology company that develops novel therapeutics by leveraging evolutionary insights from bat biology to address serious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

drug discoverybiotechnologyAI drug discoverytherapeutic discoverytarget identificationin silico drug discoverybiotech R&Dknowledge graphmulti-omic datatherapeutic pipelineAI-native biotechdrug developmentcomputational biologybiopharma partnershiptarget validation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Paratus Sciences Comparables

Compare Paratus Sciences with similar companies based on industry and business-model similarity.

Paratus Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Fauna Bio
84%
Valo Health
81%
Odyssey
79%

Paratus Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 27, 2023

Paratus Sciences Investors

Notable investors and investment history

Paratus Sciences investors
InvestorRounds
EcoR1 CapitalSeries A
ARCH Venture PartnersSeries A
ClavystBioSeries A
ARCH Venture PartnersSeries A
Alexandria Venture InvestmentsSeries A
Polaris PartnersSeries A
Leaps by BayerSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2026

    Grew 18% QoQ from 17 to 20 employees.

  • Apr 22, 2026

    Alicia Secor appointed as new President and CEO, joining the Board of Directors.

Paratus Sciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Paratus Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Paratus Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range20
Year Founded2021
Last FundingFeb 27, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.